Conditions: HIV Infections Acquired Immunodeficiency Syndrome
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 179
Healthy volunteers: no

Brief summary:
This study will investigate the safety and efficacy of different doses of an investigational drug (MK0518) as a therapy for HIV-infected patients failing current antiretroviral therapies.

Detailed description:

Arms:
arm 1: MK0518 200 mg arm 2: MK0518 400 mg arm 3: MK0518 600 mg arm 4: Placebo

Interventions: intervention 1: Comparator: MK0518 intervention 2: MK0518 intervention 3: MK0518 intervention 4: Placebo
Intervention descriptions: intervention 1: MK0518 oral tablets 200 mg b.i.d, for 24 weeks intervention 2: MK0518 oral tablets 400 mg b.i.d, for 24 weeks intervention 3: MK0518 oral tablets 600 mg b.i.d, for 24 weeks intervention 4: Placebo to MK0518, oral tablet b.i.d, for 24 weeks

Protocol document: